Episode

E132: Romosozumab vs teriparatide for osteoproosis (STRUCTURE)

Podcast
The Evidence Based Rheumatology Podcast
Published
Mar 5, 2026
Duration seconds
834
Processing state
not_requested
Canonical source
https://msputman.podbean.com/e/e132-romosozumab-vs-teriparatide-for-osteoproosis-structure/
Audio
https://mcdn.podbean.com/mf/web/6hm6dut4djraggj3/e132.mp3
JSON
/v1/public/podcasts/the-evidence-based-rheumatology-podcast-1130175/episodes/e132-romosozumab-vs-teriparatide-for-osteoproosis-structure
Markdown
/podcast/the-evidence-based-rheumatology-podcast-1130175/e132-romosozumab-vs-teriparatide-for-osteoproosis-structure.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-evidence-based-rheumatology-podcast-1130175/episodes/e132-romosozumab-vs-teriparatide-for-osteoproosis-structure/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e132-romosozumab-vs-teriparatide-for-osteoproosis-structure.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Quick podcast this week about a nifty head to head study that I had previously missed. Worth reading if - like me - you're still trying to figure out how the heck to manage osteoporosis. Paper: https://pubmed.ncbi.nlm.nih.gov/28755782/